共 30 条
[6]
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
[J].
ANNALS OF HEMATOLOGY,
2014, 93 (08)
:1371-1380
[7]
Identification of a Primary Target of Thalidomide Teratogenicity
[J].
SCIENCE,
2010, 327 (5971)
:1345-1350